Multi-Organ Protection (MOP): Targeted mRNA, Safer Results

mRNA vaccines have transformed medicine — but they also face real challenges: off-target expression in vital organs, safety concerns, and recent public criticism questioning their durability and risk profile.

At Combined Therapeutics, our Multi-Organ Protection (MOP) Platform directly tackles these issues:

✅ Tissue-specific expression to prevent off-target effects

✅ Finely regulates mRNA translation
✅ Protection of key organs (liver, heart, lung, kidney, brain)
✅ Longer-lasting immune protection — even enabling prime-only vaccination strategies
✅ Broader applications across infectious diseases, oncology, and immunology